AI makes itself better.When I see the term "recursive self-improvement," I imagine a future where AI gets smarter and smarter ...

Discover the best programming books in 2026 for software engineering, algorithms, system design, interviews, refactoring, and ...

At some point every Python developer writes a while True loop with a break, or a teetering stack of nested with blocks, and feels vaguely certain there's a better way. There usually is. The standard ...

“Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating exponential new progress — and risk. Jeff Clune, a computer scientist and ...

How do you get from a chatbot that sometimes makes things up to a machine that humans might struggle to control? There are several steps in that argument, and plenty of uncertainty. But an idea known ...

Top executives at three of the nation’s leading AI labs are calling for a slowdown in the development of advanced artificial intelligence. The comments are a rare display of consensus among competing ...

Anthropic and OpenAI researchers raised fresh concerns about recursive self-improvement, the process by which AI helps improve the development of models. Both OpenAI and Anthropic have in recent ...

Researchers at OpenAI and Anthropic are publicly urging slower AI development, as debate grows over self-improving AI and its risks. Many concerns revolve around advanced models getting incredibly ...

AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...

Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...